Display options
Cite
Macias E, Rao D, Digiovanni J. Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models. J Skin Cancer. 2013;2013:684050doi: 10.1155/2013/684050.
Macias, E., Rao, D., & Digiovanni, J. (2013). Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models. Journal of skin cancer, 2013684050. https://doi.org/10.1155/2013/684050
Macias, Everardo, et al. "Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models." Journal of skin cancer vol. 2013 (2013): 684050. doi: https://doi.org/10.1155/2013/684050
Macias E, Rao D, Digiovanni J. Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models. J Skin Cancer. 2013;2013:684050. doi: 10.1155/2013/684050. Epub 2013 Mar 21. PMID: 23577258; PMCID: PMC3618941.
Copy Download .nbib Format: NLM
Share it on

J Skin Cancer. 2013;2013:684050. doi: 10.1155/2013/684050. Epub 2013 Mar 21.

Role of stat3 in skin carcinogenesis: insights gained from relevant mouse models.

Journal of skin cancer

Everardo Macias, Dharanija Rao, John Digiovanni

Affiliations

  1. Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78723, USA.

PMID: 23577258 PMCID: PMC3618941 DOI: 10.1155/2013/684050

Abstract

Signal transducer and activator of transcription 3 (Stat3) is a cytoplasmic protein that is activated in response to cytokines and growth factors and acts as a transcription factor. Stat3 plays critical roles in various biological activities including cell proliferation, migration, and survival. Studies using keratinocyte-specific Stat3-deficient mice have revealed that Stat3 plays an important role in skin homeostasis including keratinocyte migration, wound healing, and hair follicle growth. Use of both constitutive and inducible keratinocyte-specific Stat3-deficient mouse models has demonstrated that Stat3 is required for both the initiation and promotion stages of multistage skin carcinogenesis. Further studies using a transgenic mouse model with a gain of function mutant of Stat3 (Stat3C) expressed in the basal layer of the epidermis revealed a novel role for Stat3 in skin tumor progression. Studies using similar Stat3-deficient and gain-of-function mouse models have indicated its similar roles in ultraviolet B (UVB) radiation-mediated skin carcinogenesis. This paper summarizes the use of these various mouse models for studying the role and underlying mechanisms for the function of Stat3 in skin carcinogenesis. Given its significant role throughout the skin carcinogenesis process, Stat3 is an attractive target for skin cancer prevention and treatment.

References

  1. Nucleic Acids Res. 1999 Nov 15;27(22):4324-7 - PubMed
  2. Cancer Res. 2006 May 1;66(9):4549-52 - PubMed
  3. Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62 - PubMed
  4. Science. 1994 Jun 3;264(5164):1415-21 - PubMed
  5. J Invest Dermatol. 2010 Jan;130(1):270-7 - PubMed
  6. Radiother Oncol. 2011 Jun;99(3):339-43 - PubMed
  7. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3801-4 - PubMed
  8. Cancer Res. 2005 Feb 1;65(3):939-47 - PubMed
  9. Cancer Res. 2002 Jun 15;62(12):3351-5 - PubMed
  10. Mol Cell Biol. 2004 Jan;24(1):407-19 - PubMed
  11. Cancer. 2002 May 1;94(9):2393-400 - PubMed
  12. Curr Probl Dermatol. 1980;10:193-218 - PubMed
  13. Cell Growth Differ. 2002 Aug;13(8):355-62 - PubMed
  14. J Dermatol. 2005 May;32(5):354-60 - PubMed
  15. Hepatology. 2011 Jul;54(1):164-72 - PubMed
  16. Mol Carcinog. 2007 Aug;46(8):646-53 - PubMed
  17. Mol Carcinog. 2009 Oct;48(10):873-85 - PubMed
  18. Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2361-70 - PubMed
  19. Mol Cell Biol. 1993 Jun;13(6):3176-90 - PubMed
  20. Science. 1994 Apr 1;264(5155):95-8 - PubMed
  21. Genes Dev. 2007 Jun 1;21(11):1396-408 - PubMed
  22. J Dermatol Sci. 2008 Nov;52(2):133-6 - PubMed
  23. J Invest Dermatol. 2012 Mar;132(3 Pt 2):797-810 - PubMed
  24. Cancer Discov. 2012 Aug;2(8):670-2 - PubMed
  25. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32 - PubMed
  26. J Clin Invest. 2000 Jul;106(1):3-8 - PubMed
  27. Carcinogenesis. 2008 Jun;29(6):1108-14 - PubMed
  28. Oncogene. 2000 May 15;19(21):2474-88 - PubMed
  29. PLoS One. 2010 Apr 22;5(4):e10290 - PubMed
  30. J Dermatol Sci. 2008 Sep;51(3):210-5 - PubMed
  31. EMBO J. 1999 Sep 1;18(17):4657-68 - PubMed
  32. Nat Med. 2005 Jan;11(1):43-9 - PubMed
  33. Eur J Immunol. 2010 Sep;40(9):2580-9 - PubMed
  34. Cell. 1999 Aug 6;98(3):295-303 - PubMed
  35. Nat Biotechnol. 2004 Apr;22(4):411-7 - PubMed
  36. Radiother Oncol. 2009 Sep;92(3):339-44 - PubMed
  37. Cancer Res. 2004 Apr 1;64(7):2382-9 - PubMed
  38. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Jul;33(4):331-4 - PubMed
  39. Science. 2009 Feb 6;323(5915):793-7 - PubMed
  40. Anticancer Drugs. 2011 Feb;22(2):115-27 - PubMed
  41. Gene. 2002 Feb 20;285(1-2):1-24 - PubMed
  42. Acta Pharmacol Toxicol (Copenh). 1984;55 Suppl 2:107-24 - PubMed
  43. Int J Cancer. 2013 Jan 1;132(1):109-15 - PubMed
  44. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7400-5 - PubMed
  45. J Dermatol Sci. 2008 Apr;50(1):1-14 - PubMed
  46. N Engl J Med. 1992 Dec 3;327(23):1649-62 - PubMed
  47. Oncogene. 2009 Feb 19;28(7):950-60 - PubMed
  48. Head Neck. 2013 Sep;35(9):1323-30 - PubMed
  49. Differentiation. 2004 Oct;72(8):381-6 - PubMed
  50. Curr Opin Oncol. 2000 Nov;12(6):543-9 - PubMed
  51. Nat Protoc. 2009;4(9):1350-62 - PubMed
  52. Cancer Res. 2005 Jul 1;65(13):5720-9 - PubMed
  53. Oncogene. 2000 Dec 27;19(56):6613-26 - PubMed
  54. Pharmacol Ther. 1992;54(1):63-128 - PubMed
  55. Oncogene. 2000 May 15;19(21):2468-73 - PubMed
  56. Cancer Res. 2009 Oct 1;69(19):7587-94 - PubMed
  57. Cancer Res. 2007 Feb 1;67(3):1385-94 - PubMed
  58. J Clin Invest. 2004 Sep;114(5):720-8 - PubMed
  59. Cancer Prev Res (Phila). 2011 Feb;4(2):230-7 - PubMed
  60. Genes Dev. 2008 Feb 15;22(4):449-62 - PubMed
  61. Cancer Discov. 2012 Aug;2(8):694-705 - PubMed
  62. Science. 2009 Jun 26;324(5935):1713-6 - PubMed
  63. J Clin Oncol. 2012 Mar 20;30(9):1005-14 - PubMed
  64. Oncogene. 2008 Feb 14;27(8):1087-94 - PubMed
  65. Cancer Res. 2010 Oct 15;70(20):7938-48 - PubMed
  66. Oncogene. 2000 May 15;19(21):2489-95 - PubMed
  67. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9178-82 - PubMed
  68. J Biol Chem. 2012 Nov 2;287(45):38356-66 - PubMed
  69. J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650 - PubMed

Publication Types

Grant support